BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:eec6946f-b2a8-4445-84be-1af2e862dce1
DTSTAMP:20260102T222059Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:5e1d5320-0741-48b9-b9e6-936e98704622
DTSTAMP:20260102T222059Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:9b98e78d-0db4-49ad-a8fb-5e4b3aeaa037
DTSTAMP:20260102T222059Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:805c8574-e26b-4e1d-9e4c-8b2947e3ee43
DTSTAMP:20260102T222059Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:e812dac9-828d-47c9-9bc9-8a9dcc442906
DTSTAMP:20260102T222059Z
DTSTART:20251016T090000Z
DTEND:20251016T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Self paced
END:VEVENT
BEGIN:VEVENT
UID:4eb7b3b7-7bee-4a93-8f00-ecc673f92bfb
DTSTAMP:20260102T222059Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:50ac9c43-025b-486b-ab29-be17de478c13
DTSTAMP:20260102T222059Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:ac4f2cef-26fe-4aa9-bf98-50e1ceb86852
DTSTAMP:20260102T222059Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:423a45ad-f32f-4ecf-9ad1-fb6469439b5c
DTSTAMP:20260102T222059Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:d8529ce2-3956-42d0-b03b-c46bf95047e1
DTSTAMP:20260102T222059Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:5077ed72-9e67-45aa-8f36-82ecd49d8863
DTSTAMP:20260102T222059Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:f48d30a2-42f7-420a-a0d8-92f6a36e9aa1
DTSTAMP:20260102T222059Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:7ef617c0-cf3b-49b2-8cc7-0c614efd8b36
DTSTAMP:20260102T222059Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:Live online
END:VEVENT
BEGIN:VEVENT
UID:76fd07d6-68e6-48ea-9e01-18fcbdef6533
DTSTAMP:20260102T222059Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:Self paced online
END:VEVENT
BEGIN:VEVENT
UID:347cb757-f7dd-40ae-8334-3cfab73b818b
DTSTAMP:20260102T222059Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:3921e50e-fb44-40b2-a96f-4c11b8195171
DTSTAMP:20260102T222059Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:f6f7a3c0-42cc-41c6-b1c8-d64990482f70
DTSTAMP:20260102T222059Z
DTSTART:20251205T150000Z
DTEND:20251205T160000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:e0835768-899b-4409-9502-39b7a21dbdc7
DTSTAMP:20260102T222059Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:89ba8206-ee7d-4774-b053-3ba10ae4917c
DTSTAMP:20260102T222059Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:Self-paced
END:VEVENT
BEGIN:VEVENT
UID:03df80c5-22ec-4b86-abf6-1c523f2bfbdf
DTSTAMP:20260102T222059Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:Live online
END:VEVENT
END:VCALENDAR
